Pacific Shuanglin Bio-pharmacy Hits Day High with Strong 3.44% Intraday Surge

Pacific Shuanglin Bio-pharmacy Co., a large-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable increase of 3.44% in its stock price on February 26, 2026. The stock reached an intraday high of CNY 14.36, marking a significant moment in its trading activity for the day. In terms of performance metrics, Pacific Shuanglin has shown a 4.89% increase over the past week, contrasting with a slight gain of 0.41% in the China Shanghai Composite. However, the company's longer-term performance reveals challenges, with a decline of 12.24% over the past year, while the broader index has gained 22.49%. Financially, the company reported a decrease in net sales of 12.75%, contributing to negative results over the last two quarters. The operating cash flow stands at CNY 343.73 million, and the debt-equity ratio is noted at -0.03. Despite these challenges, the stock's recent activity highlights its current market dynamics within a fluctuating industry landscape.